InsidersTradesSigma
Track the PHARMANUTRA PR stock price and the full management transaction log of the company, a publicly traded company based in Italy. Shares are quoted on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA PR has published 1 reports. Market capitalisation: €804.3m. The latest transaction was reported on 24 July 2024 (Other). All data is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,427 of 29,063 companies
61.9
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.6%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2024
关于 PHARMANUTRA PR
PHARMANUTRA PR 是一家在健康和制药领域运营的公司，在 XMIL 市场上市。它专注于营养保健品和药品的开发和营销。